Triptans may cause nausea, dizziness, and coronary vasoconstriction.

A post hoc analysis of five randomized placebo-controlled, double-blind clinical trials compared the rate of nausea associated with triptans.

Naratriptan, eletriptan, and frovatriptan are metabolized by cytochrome P-450; therefore, they may have drug-drug interaction with oral contraceptives.